Clinical trial sponsors rely on clinical quality assurance (CQA) auditors to find vulnerabilities before noncompliance can shut down their studies.
But with millions of dollars and decades of research at stake, study staffers aren’t always eager to cooperate.
That’s why even the most experienced CQA auditors must apply the necessary tools and skills to the CQA function, including how to:
Who Will Benefit
Michelle Sceppa, principal and founder of MSceppa Consulting, has more than 25 years of experience in quality assurance and regulatory compliance in the pharmaceutical and medical device industries. As a lead auditor, she has conducted and managed more than 300 internal and external audits for drug, biologic and medical device firms in the U.S. and Europe.
Ms. Sceppa has implemented and managed preclinical, clinical and manufacturing quality assurance programs for numerous clients, and has knowledge in the details of compliance with all U.S. federal regulations, including: good laboratory practice (GLP), good clinical practice (GCP) and good manufacturing practice (GMP) for drugs, biologics and medical devices.
Ms. Sceppa is also certified in the Q7A regulations for the manufacture of active pharmaceutical ingredients. Since 2002, she has been a faculty member of the Parenteral Drug Association’s (PDA) Training and Research Institute (PDA-TRI) in Baltimore, MD.
Date and Location
Nov. 7–8, 2011
Radisson Hotel Boston
200 Stuart St.
Boston, MA 02116
Toll Free: (800) 395-7046
+1 (617) 482-1800
Room rate: $249.00 plus 14.45 percent tax
Reservation cut-off date: Oct. 17, 2011
Register Early — Space Is Limited
Tuition of $1,797 includes all workshop sessions, workshop written materials, two breakfasts, two luncheons and daily refreshments.
Send Your Team for Maximum Benefit
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600
Payment is required by the date of the conference. We accept American Express, Visa and MasterCard. Make checks payable to FDAnews.
Or, register by phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600.
Written cancellations received at least 21 calendar days prior to the start date of the event will receive a refund or credit — less a $200 administration fee. No cancellations will be accepted — nor refunds issued — within 21 calendar days from the start date of the event. A credit for the amount paid may be transferred to any future FDAnews event. Substitutions may be made at any time. No-shows will be charged the full amount. In the event that FDAnews cancels the event, FDAnews is not responsible for any airfare, hotel, other costs or losses incurred by registrants. Some topics and speakers may be subject to change without notice.
Copyright ©2018. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing